2019 2022 roadmap en.pdf
ROADMAP ON VACCINATION
Last update: Q3 2019
TIMELINES AND DELIVERABLES
Consider, jointly with stakeholders, in particular with the vaccinemanufacturing industry, which has a key role in meeting these
aims, possibilities for improving EU manufacturing capacity,
ensuring continuity of supply and ensuring diversity of suppliers.
Meeting with the EU
Monitor compliance with the obligation of continuous supply
of medicines placed on marketing authorisation holders
(Article 81 of Directive 2001/83/EC) and explore ways to enhance
compliance with that obligation.
this article has been
implemented in full in
Joint procurement of
signed in March 2019
Support the EU Official Medicines Control Laboratories network
and its work to ensure that vaccines placed on the EU market are
of high quality.
Consider facilitating –together with EMA- early dialogue with
developers, national policy-makers and regulators in order to
support the authorisation of innovative vaccines, including for
emerging health threats.
and ensuring continuity
Exploit the possibilities of joint procurement of vaccines
or antitoxins to be used in cases of pandemics, unexpected
outbreaks and in case of small vaccine demand (small number of
cases or very specific populations to be covered).
Actions to facilitate early dialogue with developers, national policy-makers and regulators in order to
support the authorisation of innovative vaccines, including for emerging health threats